Facebook  Twitter  Youtube  ISSUU  RSS  Email

Advanced Search

Advanced Search Results


Search results for diagnosing bribery risk


Feb 2019 | Page

Click here to go to the Global Anti-Bribery Guidance website.       Corporate Political Engagement 2018: Rating Private Sector Political Transparency (November 2018)               Incentivising Ethics: Managing Incentives to Encourage Good and Deter Bad Behaviour (October 2016)               Managing Third Party R


Feb 2019 | Page

  The Transparency International Corporate Anti-Corruption Benchmark is a comprehensive tool that measures and compares the performance of anti-corruption programmes across companies. The methodology is based on Transparency International’s extensive anti-corruption expertise and understanding of best practice for the private sector, combined with input from experiences specialist in-house


Jun 2016 | Blog

Corruption within the pharmaceutical and healthcare sectors is a matter of life and death. It has a corrosive impact on health, negatively impacting public health budgets, the price of health services and medicines, and ultimately the quality of care dispensed. Reports estimate that as much as 6% of annual global health expenditure is lost to corruption


Jul 2013 | Blog

In the past few days, we have seen two high-profile corruption stories emanating from China – the allegations against GlaxoSmithKline (GSK) and the indictment of high-profile regional governor Bo Xilai. What should we make of them?


Contact Us | Sitemap | Privacy

UK Charity Number 1112842

Transparency International UK is a chapter of